Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using Adeno-Associated Viral Vector to Deliver the Gene for Human Factor IX Into the Liver

NCT00076557 is registered in ClinicalTrials.gov with Avigen as lead sponsor.

NCT NCT00076557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00076557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using Adeno-Associated Viral Vector to Deliver the Gene for Human Factor IX Into the Liver
Lead sponsor
Avigen
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2004
Completion date
Not reported
Enrollment
15
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b